3M Set to Announce Q1 Earnings Amid Oil Price Concerns
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 19 hours ago
0mins
Should l Buy MMM?
Source: seekingalpha
- Earnings Expectations: 3M is projected to report Q1 EPS of $1.98, reflecting a 5.3% increase, with revenue anticipated to rise 3.4% to $6 billion, demonstrating resilience amid rising oil prices.
- Market Focus: Investors are keenly watching the performance of consumer products and electronics, as weakened consumer sentiment may impact sales, particularly with elevated oil prices due to ongoing Middle East conflicts.
- Analyst Ratings: RBC Capital Markets maintains an Underperform rating on 3M while raising its price target from $125 to $134, indicating concerns over consumer electronics weakness, despite management's 3% organic growth target for 2026.
- Innovation and Transition: 3M aims to launch 350 new products in 2026, with CEO William Brown emphasizing a shift from a litigation-driven narrative to an execution-focused strategy, aiming to enhance high-margin businesses while divesting low-margin segments.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MMM?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MMM
Wall Street analysts forecast MMM stock price to fall
11 Analyst Rating
6 Buy
3 Hold
2 Sell
Moderate Buy
Current: 154.550
Low
100.00
Averages
152.00
High
184.00
Current: 154.550
Low
100.00
Averages
152.00
High
184.00
About MMM
3M Company is a diversified technology company. The Company is a manufacturer and marketer of a variety of products and services. The Company’s segments include Safety and Industrial; Transportation and Electronics, and Consumer. Its Safety and Industrial segment includes industrial abrasives and finishing for metalworking applications; autobody repair solutions; industrial specialty products, such as personal hygiene products, masking, and packaging materials, and others. Its Transportation and Electronics segment includes advanced ceramic solutions; attachment/bonding, films, sound and temperature management for transportation vehicles; premium large format graphic films for advertising and fleet signage. Its Consumer segment includes cleaning products for the home; consumer air quality products, and picture hanging accessories. Its brands include 3M Cubitron II abrasives, Scotch-Brite, Filtrete, Command, Scotchgard, Meguiar’s, Nexcare, Post-it and others.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Earnings Expectations: 3M is projected to report Q1 EPS of $1.98, reflecting a 5.3% increase, with revenue anticipated to rise 3.4% to $6 billion, demonstrating resilience amid rising oil prices.
- Market Focus: Investors are keenly watching the performance of consumer products and electronics, as weakened consumer sentiment may impact sales, particularly with elevated oil prices due to ongoing Middle East conflicts.
- Analyst Ratings: RBC Capital Markets maintains an Underperform rating on 3M while raising its price target from $125 to $134, indicating concerns over consumer electronics weakness, despite management's 3% organic growth target for 2026.
- Innovation and Transition: 3M aims to launch 350 new products in 2026, with CEO William Brown emphasizing a shift from a litigation-driven narrative to an execution-focused strategy, aiming to enhance high-margin businesses while divesting low-margin segments.
See More
- Market Weakness: U.S. stocks closed lower on Monday due to ceasefire uncertainty and stalled negotiations, with the Nasdaq Composite declining by 0.3% to 24,404.39, indicating a drop in investor sentiment.
- Dow Jones Dynamics: The Dow Jones Industrial Average fell by 0.01%, or 4.87 points, closing at 49,442.56, with 17 of its 30 components in the red, reflecting widespread market weakness.
- 3M Company Underperformance: 3M's stock price dropped by 2%, currently holding a Zacks Rank of #3 (Hold), indicating vulnerability in the current market environment that may affect its future investment appeal.
- Decreased Trading Volume: Monday's trading volume was 16.42 billion shares, lower than the 20-session average of 18.54 billion, suggesting a decline in market participation that could lead to increased price volatility.
See More
- Portfolio Growth: Over the past decade, the S&P 500 has surged approximately 240%, which is excellent news for long-term investors; however, failing to adjust portfolios may lead to individual stocks representing a disproportionately high percentage, increasing risk exposure.
- Risks of Rebalancing: Annual rebalancing may force investors to sell top-performing stocks, potentially missing out on significant long-term gains, particularly for stocks like Nvidia, which have excelled over the past decade, leading to regret if sold prematurely.
- Tax Implications: Selling stocks that have appreciated significantly can trigger substantial capital gains taxes, especially for stocks held for less than a year, thereby increasing the tax burden on investors.
- Investment Strategy Choices: While rebalancing helps manage risk, long-term holding of high-performing stocks often yields better returns, prompting investors to choose strategies that align with their individual circumstances and risk tolerance.
See More
- 3M Options Volume: 3M Co's options trading volume reached 23,355 contracts, equivalent to approximately 2.3 million shares, representing about 75.4% of its average daily trading volume of 3.1 million shares over the past month, indicating strong market interest in the stock.
- High-Frequency Contracts: Notably, the $160 strike call option expiring on April 24, 2026, saw 5,578 contracts traded today, representing around 557,800 underlying shares, suggesting investor optimism regarding 3M's future performance.
- Lemonade Options Activity: Lemonade Inc's options trading volume stood at 11,415 contracts, approximately 1.1 million shares, accounting for 69.1% of its average daily trading volume of 1.7 million shares over the past month, reflecting heightened market attention to its stock price fluctuations.
- Key Contract Analysis: The $62 strike put option expiring on April 24, 2026, recorded a trading volume of 1,294 contracts, representing about 129,400 shares, indicating a cautious investor sentiment regarding Lemonade's future risks.
See More
- Successful Restructuring: The management team has effectively restructured the business to align with current market realities, enhancing operational efficiency and competitive positioning, which is expected to positively impact future performance.
- Stable Stock Performance: As of the afternoon of April 16, 2026, the company's stock price remained stable, reflecting market confidence in the management's restructuring strategy and boosting investor sentiment.
- Strategic Adjustment Context: This restructuring was initiated to address the evolving market environment, with management optimizing resource allocation and process improvements to enhance overall business agility and responsiveness.
- Positive Future Outlook: The management team's efforts not only improved current operational conditions but also laid a solid foundation for future growth, likely attracting increased investor interest.
See More
- Honeywell Business Sale: Honeywell sells its Productivity Solutions and Services (PSS) business to Brady Corporation for $1.4 billion in cash, a strategic move to divest cyclical, slower-growing, lower-margin operations, thereby enhancing the overall quality of its portfolio.
- Market Reaction Stable: Despite a 5% rise in oil prices due to uncertainty over commercial shipping traffic in the Strait of Hormuz, the market's decline was less severe than feared, as Treasury yields remained relatively unchanged, indicating a stable investor sentiment.
- Eli Lilly Acquisition Moves: Eli Lilly acquires clinical-stage biotech firm Kelonia Therapeutics for $3.25 billion in cash, aiming to bolster its cancer treatment pipeline, with the deal potentially worth up to $7 billion, showcasing the company's aggressive expansion strategy in oncology.
- Active IPO Market: In spite of uncertainties from the Iran conflict, Jersey Mike's confidentially files for an IPO with a valuation of approximately $8 billion, reflecting ongoing interest in new public offerings and further driving growth in investment banking activities.
See More











